Dusp5 negatively regulates IL‐33‐mediated eosinophil survival and function |
| |
Authors: | Derek A Holmes Jung‐Hua Yeh Donghong Yan Min Xu Andrew C Chan |
| |
Affiliation: | 1. Department of Immunology, Genentech, Inc., South San Francisco, CA, USA;2. Department of Translational Immunology, Genentech, Inc., South San Francisco, CA, USA |
| |
Abstract: | Mitogen-activated protein kinase (MAPK) activation controls diverse cellular functions including cellular survival, proliferation, and apoptosis. Tuning of MAPK activation is counter-regulated by a family of dual-specificity phosphatases (DUSPs). IL-33 is a recently described cytokine that initiates Th2 immune responses through binding to a heterodimeric IL-33Rα (ST2L)/IL-1α accessory protein (IL-1RAcP) receptor that coordinates activation of ERK and NF-κB pathways. We demonstrate here that DUSP5 is expressed in eosinophils, is upregulated following IL-33 stimulation and regulates IL-33 signaling. Dusp5−/− mice have prolonged eosinophil survival and enhanced eosinophil effector functions following infection with the helminth Nippostrongylus brasiliensis. IL-33-activated Dusp5−/− eosinophils exhibit increased cellular ERK1/2 activation and BCL-XL expression that results in enhanced eosinophil survival. In addition, Dusp5−/− eosinophils demonstrate enhanced IL-33-mediated activation and effector functions. Together, these data support a role for DUSP5 as a novel negative regulator of IL-33-dependent eosinophil function and survival. |
| |
Keywords: | BCL‐XL eosinophil survival dual‐specificity phosphatase 5 |
|
|